Suli’s 2021 net profit increases 30%, as sale and price of azoxystrobin increase

Chinese agrochemical company Jiangsu Suli Co., Ltd announced its 2021 annual performance report on January 13, 2022.

During the reporting period, the company achieved operating revenue of Yuan2.2840192 billion, a year-on-year increase of 46.54% and net profit attributable to the listed parent company of Yuan226.44 million which is a year-on-year increase of 29.58%. 

At the end of the reporting period the total assets were Yuan3.8441069 billion, an increase of 25.29% over the beginning of the year. The owner’s equity attributable to the listed parent company was Yuan2.1985742 billion, an increase of 8.39% over the beginning of the year.

Due to the gradual recovery of the global chemical market and the production of DBDPE being gradually brought to design capacity, the selling prices of the company’s DBDPE, azoxystrobin technical and hydrobromic acid during the reporting period have all shown growth. This contributed to the substantial growth of the company’s operating revenue and net profit.